PTSD Trial, Recruiting NCT04672551 Sponsor: University of Zurich Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT04672551
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 70 years of age
  • Men or women are eligible
  • People who have had a heart attack (either with specific electrical changes on a heart tracing called ST-elevation, or confirmed by a blood protein marker called troponin), as confirmed by a heart specialist
  • People who have been diagnosed with PTSD (post-traumatic stress disorder) that was caused by their heart attack experience

Who may not be able to join:

  • People who have a psychotic disorder, bipolar disorder, or a substance use problem, as identified through a specific psychiatric interview tool
  • People who are currently having thoughts of suicide, as identified through a specific psychiatric interview tool
  • People who are taking certain blood pressure medications known as non-selective beta blockers (for example, propranolol) during the study period
  • People who are already receiving psychological or psychiatric treatment outside of this trial during the study period
  • People who have vision problems, such as a condition where the eyes do not move together properly (for example, a squint), that would prevent them from doing eye movement exercises
  • People who do not have sufficient knowledge of the German language
  • People who are not expected to be able or willing to follow the study's requirements
  • People who regularly take medications called benzodiazepines

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Christoph Mueller-Pfeiffer, PD Dr. med., University of Zurich/University Hospital Zurich

Phone: +41 44 255 52 80

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 November 2020
Est. completion
30 November 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Interview-rated posttraumatic stress 3 months Follow-up; Interview-rated posttraumatic stress 6 months Follow-up

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov